277 related articles for article (PubMed ID: 36964529)
1. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
[TBL] [Abstract][Full Text] [Related]
2. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
[TBL] [Abstract][Full Text] [Related]
3. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract][Full Text] [Related]
4. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases.
Das S; Faruqi S; Nordal R; Starreveld Y; Kelly J; Bowden G; Amanie J; Fairchild A; Lim G; Loewen S; Rowe L; Wallace C; Ghosh S; Patel S
BMC Cancer; 2022 Dec; 22(1):1368. PubMed ID: 36585629
[TBL] [Abstract][Full Text] [Related]
5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
6. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
[TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery.
Choi SW; Cho KR; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
J Neurooncol; 2019 Dec; 145(3):571-579. PubMed ID: 31705245
[TBL] [Abstract][Full Text] [Related]
8. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
9. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.
Minniti G; Paolini S; D'Andrea G; Lanzetta G; Cicone F; Confaloni V; Bozzao A; Esposito V; Osti M
J Neurooncol; 2017 May; 132(3):455-462. PubMed ID: 28260130
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes and Prognostic Factors of Fractionated Stereotactic Radiosurgery for Brain Metastases ≥20 mm as a Potential Alternative to Surgery.
Ogawa H; Ito K; Karasawa K
World Neurosurg; 2022 Jun; 162():e141-e146. PubMed ID: 35247616
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases.
Minniti G; Lanzetta G; Capone L; Giraffa M; Russo I; Cicone F; Bozzao A; Alongi F; Nicosia L; Fineschi G; Marchetti L; Tufo T; Bianciardi F; Esposito V; Gentile P; Paolini S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949695
[TBL] [Abstract][Full Text] [Related]
13. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
[TBL] [Abstract][Full Text] [Related]
14. Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis.
Minniti G; Scaringi C; Paolini S; Lanzetta G; Romano A; Cicone F; Osti M; Enrici RM; Esposito V
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1142-8. PubMed ID: 27209508
[TBL] [Abstract][Full Text] [Related]
15. The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.
Yamada T; Ohtakara K; Kamomae T; Itoh J; Shimada H; Ishihara S; Naganawa S
Cureus; 2022 Jun; 14(6):e25888. PubMed ID: 35844334
[TBL] [Abstract][Full Text] [Related]
16. Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases.
Cleary RK; Meshman J; Dewan M; Du L; Cmelak AJ; Luo G; Morales-Paliza M; Weaver K; Thompson R; Chambless LB; Attia A
Cureus; 2017 May; 9(5):e1279. PubMed ID: 28656127
[TBL] [Abstract][Full Text] [Related]
17. Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials.
Lehrer EJ; Peterson JL; Zaorsky NG; Brown PD; Sahgal A; Chiang VL; Chao ST; Sheehan JP; Trifiletti DM
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):618-630. PubMed ID: 30395902
[TBL] [Abstract][Full Text] [Related]
18. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
[TBL] [Abstract][Full Text] [Related]
20. Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases.
Rana N; Pendyala P; Cleary RK; Luo G; Zhao Z; Chambless LB; Cmelak AJ; Attia A; Stavas MJ
Front Oncol; 2017; 7():279. PubMed ID: 29218301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
